The Holistic Value of Targeted Time-Limited Therapy in Chronic Lymphocytic Leukemia

Clinical Perspectives presented by:

Lindsey Roeker, MD

Assistant Attending Physician

Memorial Sloan Kettering

Cancer Center

Bita Fakhri, MD, MPH

Assistant Professor of Medicine (Hematology)

Stanford Health Care

Program Objectives

Learn CLL Disease State and Goals of Treatment

Explore Updates in CLL Treatment: 5-Year Off-Treatment Analyses of the CLL14 and MURANO Trials

Review CLL Patient Management Considerations

All content has been developed and authored

by AbbVie US Medical Affairs.


This site is intended for U.S. Healthcare Professionals only. Use of and access to this site are subject to the Terms of Use and Privacy Policy.


Copyright © 2024 AbbVie Inc. North Chicago, Illinois, U.S.A. BCL2-US-00073-MC, March 2024